In addition, epigenetic activation of LOX via lncRNA/miR-29c has also been demonstrated to facilitate M2 macrophage polarization and tumor immune escape, finally rendering tumor cells resistant to chemotherapeutic drugs in gastric cancer (Nai et al., 2021). This evidence concerns the gene LOX and gastric cancer.